BG IRIS Research Client Login
Transactions
Services
Overview
Solutions
Sector expertise
Research
Insights
Overview
White Papers
Blog
Reports
About us
Overview
Senior Team
News
Events
Careers
Overview
Early careers
Experienced hires
Employee Growth Stories
Media
Press
Videos
Contact
Search
BG IRIS Research Client Login
Healthcare
Bryan, Garnier & Co acts as Joint Bookrunner to BioNTech on its USD 150 million Nasdaq Initial Public Offering
Bryan, Garnier & Co acts as Joint Bookrunning Manager on Celyad’s USD 20 million global equity offering
Bryan, Garnier & Co acts as Sole Financial Advisor to Inotrem on its EUR 44 million Series B Fundraising
Bryan, Garnier & Co advised LIFCO on its acquisition of Physics Forceps dental product assets from GoldenDent
Bryan, Garnier & Co makes significant move into the Nordics with the acquisition of Beringer Finance
Bryan, Garnier & Co acts as Joint Bookrunner to Genfit on its $155.4 million Nasdaq Initial Public Offering
Bryan, Garnier & Co acts as Sole Financial Advisor to Activa Capital and Turenne Capital on the acquisition of Medisys
Bryan, Garnier & Co acts as Sole Financial Advisor to HighLife on its €32 million Series B Fundraising
Bryan, Garnier & Co acts as Sole Financial Advisor to life insurance platform Quality Insurance Services on its sale to CNP Assurances
Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner for MedinCell’s €30 million Euronext Paris IPO
1
…
7
8
9
10
11
…
18
Privacy Preference Center
Privacy Preferences